首页> 外文期刊>Expert opinion on therapeutic targets >Transcription factors as therapeutic targets for diabetes.
【24h】

Transcription factors as therapeutic targets for diabetes.

机译:转录因子作为糖尿病的治疗靶标。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Islet cell implantation and pancreas transplantation have been used as treatments for diabetes but are limited by the shortage of donors and the requirement for lifelong immunosuppression. As an alternative, the generation of surrogate insulin-producing cells has been an area of interest for many researchers. Understanding how pancreatic beta-cells are generated during pancreas development will provide information that can be applied to generating surrogate beta-cells. OBJECTIVE: To outline the current knowledge of pancreas development and differentiation, with a focus on the regulatory network of pancreas-enriched transcription factors and their targets. METHODS: A review of relevant literature. CONCLUSIONS: Pancreatic and duodenal homeobox 1 (Pdx1), Neurogenin 3 (Ngn3), and musculoaponeurotic fibrosarcoma oncogene homolog A (MafA) have been shown to play essential roles in pancreas development and beta-cell differentiation, and gain-of-function approaches indicate the potency of these factors for inducing differentiation of non-beta-cells into insulin-producing cells, which could lead to a novel therapy to cure diabetes.
机译:背景:胰岛细胞移植和胰腺移植已被用作糖尿病的治疗方法,但由于捐赠者的短缺和终身免疫抑制的需求而受到限制。作为替代方案,代孕胰岛素产生细胞的产生已成为许多研究人员关注的领域。了解胰腺发育过程中胰腺β细胞的产生方式将提供可用于产生替代β细胞的信息。目的:概述目前胰腺发育和分化的知识,重点是富含胰腺的转录因子及其靶标的调控网络。方法:相关文献综述。结论:胰腺和十二指肠同源盒1(Pdx1),神经生成素3(Ngn3)和肌腱膜纤维肉瘤癌基因同系物A(MafA)已被证明在胰腺发育和β细胞分化中起重要作用,并且功能获得方法表明这些因素诱导非β细胞分化为产生胰岛素的细胞的效力,这可能会导致治愈糖尿病的新疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号